切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2017, Vol. 07 ›› Issue (03) : 118 -124. doi: 10.3877/cma.j.issn.2095-2015.2017.03.006

所属专题: 文献

循证医学

内镜下套扎与口服β受体阻滞剂对预防初次食管胃底静脉曲张破裂出血的Meat分析
张伟1, 田昭涛1, 崔云亮1,()   
  1. 1. 250012 济南军区总医院重症医学科
  • 收稿日期:2017-04-21 出版日期:2017-06-01
  • 通信作者: 崔云亮

Endoscopic varices ligation vs. β-blocker for primary prophylaxis of varices bleeding: a Meta-analysis

Wei Zhang1, Zhaotao Tian1, Yunliang Cui1,()   

  1. 1. Department of Critical Care Medicine, Jinan Military General Hospital, Jinan 250031, China
  • Received:2017-04-21 Published:2017-06-01
  • Corresponding author: Yunliang Cui
  • About author:
    Corresponding author: Cui Yunliang, Email:
引用本文:

张伟, 田昭涛, 崔云亮. 内镜下套扎与口服β受体阻滞剂对预防初次食管胃底静脉曲张破裂出血的Meat分析[J/OL]. 中华消化病与影像杂志(电子版), 2017, 07(03): 118-124.

Wei Zhang, Zhaotao Tian, Yunliang Cui. Endoscopic varices ligation vs. β-blocker for primary prophylaxis of varices bleeding: a Meta-analysis[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2017, 07(03): 118-124.

目的

比较内镜下食管胃底静脉曲张套扎术(endoscopic varices ligation,VEL)与口服β受体阻滞剂对预防初次静脉曲张破裂出血的效果。

方法

检索Pubmed/Medicine、中国生物医学文献服务系统等数据库,已发表关于静脉曲张行套扎术与口服β受体阻滞剂对预防静脉曲张初次出血的临床随机对照研究,检索时间限制到2016年4月。由2位作者对检索文献进行数据提取、质量评价,运用Stata 12.0软件对数据进行统计分析。

结果

共检索文献545篇,纳入14篇,样本量1 441例,结果显示荟萃分析静脉曲张套扎术与普萘洛尔和卡维地洛在预防曲张静脉首次出血率、出血病死率、总死亡率及不良反应方面分别为:套扎术vs.普萘洛尔首次出血率RR=0.78(95% CI 0.59~1.03),I2=11%,P=0.34;套扎术vs.卡维地洛首次出血率RR=1.54(95% CI 0.69~3.42),I2=38.8%,P=0.20,套扎术vs.普萘洛尔出血死亡率RR=0.83(95% CI 0.52~1.34),I2=0,P=0.954;套扎术vs.卡维地洛出血死亡率RR=0.84(95% CI 0.29~2.46),I2=0,P=0.770,套扎术vs.普萘洛尔总死亡率RR=1.08(95% CI 0.88~1.32),I2=0,P=0.837;套扎术vs.卡维地洛总死亡率RR=0.91(95% CI 0.58~1.42),I2=25.2%,P=0.248;套扎术vs.β受体阻滞剂不良反应发生率RR=1.19(95% CI 0.81~1.77),I2=87.3%,P=0。

结论

食管胃底静脉曲张患者行套扎术治疗与口服β受体阻滞剂方面在首次出血率、出血病死率、总死亡率及不良反应方面均无明显差异,但考虑到患者依从性、医疗负担等方面,临床建议口服β受体阻滞剂预防静脉曲张首次出血。

Objective

To evaluate the efficacy of endoscopic varices ligation(EVL)andβ-blocker for prophylaxis of oesophageal-gastric varices bleeding.

Methods

PubMed/Medicine, Chinese biomedical literature service system and other databases were searched for relevant clinical randomized controlled trials about EVL andβ-blocker for prophylaxis of oesophageal-gastric varices bleeding published before April 2016.Two authors independently assessed study quality and extracted data.Stata12.0 software was used to statistically analyze the data.

Results

Fourteen studies including 1 441 cases were included.This Meta-analysis results were as follows: bleeding rate for the first time: EVL vs.propranolol(RR=0.78, 95% CI: 0.59-1.03, I2=11%, P=0.34), EVL vs.carvedilol(RR=1.54, 95% CI: 0.69-3.42, I2=38.8%, P=0.20); bleeding related mortality: EVL vs.propranolol(RR=0.83, 95% CI: 0.52-1.34, I2=0%, P=0.954), EVL vs.carvedilol(RR=0.84, 95% CI: 0.29-2.46, I2=0%, P=0.770); total mortality: EVL vs.propranolol(RR=1.08, 95% CI: 0.88-1.32, I2=0%, P=0.837), EVL vs.carvedilol(RR=0.91, 95% CI: 0.58-1.42, I2=25.2%, P=0.248); adverse effects rate: EVL vs.β-blocker(RR=1.19, 95% CI: 0.81-1.77, I2=87.3%, P=0).

Conclusions

There are no significant differences on preventing for the primary varices bleeding in first bleeding rate, bleeding related mortality, total mortality and adverse effects rate between EVL andβ-blocker.But considering the cost and compliance, we recommend the best choice for preventing on the primary bleeding isβ-blocker.

图1 EVL组与PPL和CAR组比较预防静脉曲张首次出血率的比较
图2 不同地区分布人群EVL组与β-受体阻滞剂组比较预防静脉曲张首次出血率的比较
图3 EVL组与PPL和CAR组比较预防静脉曲张出血相关死亡率的比较
图4 EVL组与PPL和CAR组比较预防静脉曲张出血总死亡率的比较
图5 EVL组与β-受体阻滞剂组比较预防静脉曲张出血不良反应的比较
1
Jensen DM.Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes[J]. Gastroenterology, 2002, 122(6): 1620-1630.
2
North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices.Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices.A prospective multicenter study[J]. N Engl J Med, 1988, 319(15): 983-989.
3
Kleber G, Sauerbruch T, Ansari H, et al.Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study[J]. Gastroenterology, 1991, 100(5 Pt 1): 1332-1337.
4
De Franchis R, Primignani M, Arcidiacono PG, et al.Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria.A multicenter randomized controlled trial[J]. Gastroenterology, 1991, 101(4): 1087-1093.
5
Nevens F, Bustami R, Scheys I, et al.Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients[J]. Hepatology, 1998, 27(1): 15-19.
6
Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial[J]. The PROVA Study Group.Hepatology, 1991, 14(6): 1016-1024.
7
Imperiale TF, McCullough AJ.Prophylactic beta-blocker therapy: clinical implications of an aggregate analysis[J]. Hepatology, 1992, 15(2): 354-356.
8
Jadad AR, Moore RA, Carroll D, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary? [J]. Control Clin Trials, 1996, 17(1): 1-12.
9
Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses[J]. Ann Intern Med, 2001, 135(11): 982-989.
10
Moher D, Pham B, Jones A, et al.Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses? [J]. Lancet, 1998, 352(9128): 609-613.
11
De BK, Ghoshal UC, Das T, et al.Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: Preliminary report of a randomized controlled trial[J]. J Gastroenterol Hepatol, 1999, 14(3): 220-224.
12
Sarin SK, Lamba GS, Kumar M, et al.Comparison of endoscopic ligation and propranolol for the primary prevention of varicealbleeding[J]. N Engl J Med, 1999, 340(13): 988-992.
13
Lui HF, Stanley AJ, Forrest EH, et al.Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing bandligation, propranolol, and isosorbide mononitrate[J]. Gastroenterology, 2002, 123(3): 735-744.
14
Schepke M, Kleber G, Nürnberg D, et al.Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis[J]. Hepatology, 2004, 40(1): 65-72.
15
Jutabha R, Jensen DM, Martin P, et al.Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices[J]. Gastroenterology, 2005, 128(4): 870-881.
16
Psilopoulos D, Galanis P, Goulas S, et al.Endoscopic variceal ligation vs.propranolol for prevention of first variceal bleeding: a randomized controlled trial[J]. Eur J Gastroenterol Hepatol, 2005, 17(10): 1111-1117.
17
Lay CS, Tsai YT, Lee FY, et al.Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis[J]. J Gastroenterol Hepatol, 2006, 21(2): 413-419.
18
Norberto L, Polese L, Cillo U, et al.A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation[J]. Liver Transpl, 2007, 13(9): 1272-1278.
19
Tripathi D, Ferguson JW, Kochar N, et al.Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed[J]. Hepatology, 2009, 50(3): 825-833.
20
Pérez-Ayuso RM, Valderrama S, Espinoza M, et al.Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleedingin cirrhotic patients with high risk esophageal varices[J]. Ann Hepatol, 2010, 9(1): 15-22.
21
Drastich P, Lata J, Petrtyl J, et al.Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding[J]. Ann Hepatol, 2011, 10(2): 142-149.
22
冯超,黄飞舟,聂晚频,等.内镜下套扎术与普萘洛尔预防肝硬化食管胃底静脉曲张首次出血的对照研究[J].中南大学学报(医学版),2012,37(5):513-516.
23
卢永福,郜茜,王韵,等.食管静脉曲张套扎术和口服普萘洛尔治疗肝硬化食管静脉曲张的疗效对比[J].世界华人消化杂志,2013,21(26):2694-2697.
24
Shah HA, Azam Z, Rauf J, et al.Carvedilol vs.esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: A multicentre randomized controlled trial[J]. J Hepatol, 2014, 60(4): 757-764.
25
张海月,王鲁文,龚作炯.内镜套扎与普萘洛尔预防肝硬化食管静脉曲张首次出血效能的Meta分析[J].实用肝脏病杂志,2013,16(5):436-438.
26
常万华,严燕.内镜套扎与普萘洛尔治疗肝硬化食管胃底静脉曲张一级预防Meta分析[D].大连:大连医科大学,2014.
[1] 蒙燕, 唐如冰, 蒋奕, 陆华, 苏玉兰, 张琼, 何英煜. 基于多学科协作的预防性淋巴管-静脉吻合术在乳腺癌腋窝淋巴结清扫患者中的应用[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 204-207.
[2] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[3] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[4] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[5] 朱俊佳, 孙琦, 徐文龙, 陆天宇, 冯强, 储涛, 邢春根, 高春冬, 俞一峰, 赵振国. 永久性结肠造口预防性补片置入对预防造口旁疝价值的Meta分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 336-342.
[6] 赵信燕, 岳晓霞, 曹瑞玲, 张惠丽, 李向杰. 急性肺栓塞影像学及临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 296-299.
[7] 杨凤霞, 张英, 尤楠, 王霞, 黄小兵, 冯欢. 原位肝移植术后肺部并发症的诊疗进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 329-331.
[8] 李干斌, 侯睿, 郭雅萍, 张潇, 邱小原, 牛备战, 林国乐. 改良经辅助切口回肠造口在腹腔镜直肠癌根治术的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 271-276.
[9] 张宇, 余灵祥, 赵亮, 张宁, 赵德希, 刁广浩, 杨木易, 刘佳, 李鹏, 任辉. 利伐沙班在脾切除联合贲门周围血管离断术后门静脉血栓预防中的疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 195-199.
[10] 周璐, 温镕博, 刘子璇, 李奕飏, 周乐其, 朱晓明, 龚海峰, 高显华, 楼征, 刘连杰, 郝立强, 于冠宇, 张卫. Changhai-AL-Prediction预测模型指导预防性造口合理实施的卫生经济学研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 280-287.
[11] 李佳曦, 刘子源, 李学民. 二甲双胍对年龄相关性白内障影响的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(04): 252-256.
[12] 陈芳, 王建英, 曹建用, 刘丽, 罗晓琴. 基于分析-设计-开发-实施-评价模式的叙事护理培训在产科预防性介入治疗中的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 392-396.
[13] 鲍小倩, 王盈盈, 王俊雅, 王晨. 十二指肠镜预防性维护对策在降低故障维修中的应用[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(02): 132-134.
[14] 李兰兰, 龚忆华, 陈泳欣, 郑纯翠, 易石坚. 失效模式和效果分析模式提高医院保洁人员标准预防依从性的效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 277-280.
[15] 庄建彬, 杨明建. 肥胖与结直肠癌的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 120-126.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?